YOU ARE ABOUT TO EXIT A US HEMANEXT CORPORATE WEBSITE FOR A GLOBAL HEMANEXT ONE PRODUCT WEBSITE
Please be aware that the website you have requested is intended for the residents of countries in the European Union. The site may contain information on products or uses of those products that are not cleared, approved, or otherwise authorized in all countries or regions, including the US Food & Drug Administration.
WITH DO YOU WISH TO CONTINUE AND EXIT THIS WEBSITE?
Hemanext to Present New Red Blood Cell Research Data at AABB 2020 Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs LEXINGTON, Mass., September 29, 2020 Hemanext Inc., a privately held medical technology company dedicated to...
Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance Organizations create partnership to support the needs of people living with hemoglobin disorders NICOSIA, Cyprus and LEXINGTON, Mass., June 10, 2020 The Thalassaemia International...